299 related articles for article (PubMed ID: 28286901)
21. Differential network analysis and protein-protein interaction study reveals active protein modules in glucocorticoid resistance for infant acute lymphoblastic leukemia.
Mousavian Z; Nowzari-Dalini A; Rahmatallah Y; Masoudi-Nejad A
Mol Med; 2019 Aug; 25(1):36. PubMed ID: 31370801
[TBL] [Abstract][Full Text] [Related]
22. Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.
Lauten M; Cario G; Asgedom G; Welte K; Schrappe M
Haematologica; 2003 Nov; 88(11):1253-8. PubMed ID: 14607754
[TBL] [Abstract][Full Text] [Related]
23. NFkappaB modulators in a model of glucocorticoid resistant, childhood acute lymphoblastic leukemia.
Nicholson L; Hall AG; Redfern CP; Irving J
Leuk Res; 2010 Oct; 34(10):1366-73. PubMed ID: 20106524
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia.
Rainer J; Ploner C; Jesacher S; Ploner A; Eduardoff M; Mansha M; Wasim M; Panzer-Grümayer R; Trajanoski Z; Niederegger H; Kofler R
Leukemia; 2009 Apr; 23(4):746-52. PubMed ID: 19148136
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoid receptor alpha, beta and gamma expression vs in vitro glucocorticod resistance in childhood leukemia.
Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
Leukemia; 2004 Mar; 18(3):530-7. PubMed ID: 14724649
[TBL] [Abstract][Full Text] [Related]
26. A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL.
Han BW; Feng DD; Li ZG; Luo XQ; Zhang H; Li XJ; Zhang XJ; Zheng LL; Zeng CW; Lin KY; Zhang P; Xu L; Chen YQ
Hum Mol Genet; 2011 Dec; 20(24):4903-15. PubMed ID: 21926415
[TBL] [Abstract][Full Text] [Related]
27. An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways.
Lv M; Zhang X; Jia H; Li D; Zhang B; Zhang H; Hong M; Jiang T; Jiang Q; Lu J; Huang X; Huang B
Leukemia; 2012 Apr; 26(4):769-77. PubMed ID: 21979877
[TBL] [Abstract][Full Text] [Related]
28. Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies.
Clarisse D; Van Wesemael K; Tavernier J; Offner F; Beck IM; De Bosscher K
PLoS One; 2018; 13(5):e0197000. PubMed ID: 29738549
[TBL] [Abstract][Full Text] [Related]
29. Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia.
Bhadri VA; Trahair TN; Lock RB
J Paediatr Child Health; 2012 Aug; 48(8):634-40. PubMed ID: 22050419
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoid Resistance: Interference between the Glucocorticoid Receptor and the MAPK Signalling Pathways.
Sevilla LM; Jiménez-Panizo A; Alegre-Martí A; Estébanez-Perpiñá E; Caelles C; Pérez P
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576214
[TBL] [Abstract][Full Text] [Related]
31. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R
Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoid-induced granzyme A expression can be used as a marker of glucocorticoid sensitivity for acute lymphoblastic leukemia therapy.
Myoumoto A; Nakatani K; Koshimizu TA; Matsubara H; Adachi S; Tsujimoto G
J Hum Genet; 2007; 52(4):328-333. PubMed ID: 17310274
[TBL] [Abstract][Full Text] [Related]
33. Chronic Stress and Glucocorticoid Receptor Resistance in Asthma.
Palumbo ML; Prochnik A; Wald MR; Genaro AM
Clin Ther; 2020 Jun; 42(6):993-1006. PubMed ID: 32224031
[TBL] [Abstract][Full Text] [Related]
34. Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia.
Tissing WJ; Meijerink JP; den Boer ML; Brinkhof B; van Rossum EF; van Wering ER; Koper JW; Sonneveld P; Pieters R
Clin Cancer Res; 2005 Aug; 11(16):6050-6. PubMed ID: 16115950
[TBL] [Abstract][Full Text] [Related]
35. Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment.
Song QQ; Xie WY; Tang YJ; Zhang J; Liu J
Pharmacogenomics; 2017 Feb; 18(3):293-316. PubMed ID: 28112586
[TBL] [Abstract][Full Text] [Related]
36. Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia.
Kruth KA; Fang M; Shelton DN; Abu-Halawa O; Mahling R; Yang H; Weissman JS; Loh ML; Müschen M; Tasian SK; Bassik MC; Kampmann M; Pufall MA
Blood; 2017 Jun; 129(22):3000-3008. PubMed ID: 28424165
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy.
Hapgood JP; Avenant C; Moliki JM
Pharmacol Ther; 2016 Sep; 165():93-113. PubMed ID: 27288728
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance.
Schmidt S; Rainer J; Ploner C; Presul E; Riml S; Kofler R
Cell Death Differ; 2004 Jul; 11 Suppl 1():S45-55. PubMed ID: 15243581
[TBL] [Abstract][Full Text] [Related]
39. Current concepts in glucocorticoid resistance.
Yang N; Ray DW; Matthews LC
Steroids; 2012 Sep; 77(11):1041-9. PubMed ID: 22728894
[TBL] [Abstract][Full Text] [Related]
40. High-Throughput Sequencing of microRNAs in Glucocorticoid Sensitive Paediatric Inflammatory Bowel Disease Patients.
De Iudicibus S; Lucafò M; Vitulo N; Martelossi S; Zimbello R; De Pascale F; Forcato C; Naviglio S; Di Silvestre A; Gerdol M; Stocco G; Valle G; Ventura A; Bramuzzo M; Decorti G
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29738455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
